Latest Off-label use Stories
Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had been allegedly paid by pharmaceutical manufacturers as part of off-label marketing programs are often inadequate, highlighting the deficiencies in relying on author candidness and the weaknesses in some journal practices in ensuring proper disclosure.
Many people have probably heard of off-label drug use, but they may not know when that applies to prescriptions they are taking.
Purdue Pharma, the maker of the widely-used, and equally-abused drug, OxyContin, is now looking to gain 6 extra months of patent protection with new clinical trials that could possibly see market of the drug to children.
Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care.
In the eyes of young college men, it's more unethical to use steroids to get an edge in sports than it is to use prescription stimulants to enhance one's grades.
A new study from the Université de Montréal shows an increase in prevalence of Canadian children diagnosed with attention-deficit hyperactivity disorder (ADHD) and in the use of medications associated with ADHD in school-age children.